Faster global financial news!
RedHill Biopharma (RDHL) acquires commercialization rights for Rebyota and Clenpiq for $12 million upfront, with the two products' combined sales reaching $37.5 million in 2025.
The transaction involves the global exclusive commercialization rights for Rebyota and the US exclusive commercialization rights for Clenpiq, sold by Ferring Pharmaceuticals. The agreement has an initial term of 13 years and includes tiered sales royalties ranging from 5% to 20%, along with other contingent payments.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source：Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
Previous: Analysis: CoreWeave (CRWV) stock has been on a downtrend since April, falling nearly 5% on Wednesday, with analysts suggesting it's suitable for put option strategies.
|
Next: SolarEdge shares fell 4% on analyst day, despite the release of an 800 VDC power framework in collaboration with NVIDIA; investors focused more on revenue timing than lab results.
24H Trending
-
1
NVS Coin: Project Status, Trading Channels, and High-Risk Warning
-
2
What is Fantom (FTM)? FTM Token Analysis and Future Outlook
-
3
BMP Token Analysis: Cryptocurrency with Multiple Identities and Investment Considerations
-
4
What is ELCASH Coin? Electric Cash Token Analysis and Trading Channels
-
5
Key Differences Between US and A-Share Markets: A Five-Core Mechanism Analysis
-
6
NUKE Coin: A Multifaceted Analysis of Homonymous Tokens in the Robinhood Ecosystem, Gaming, and Payment Solutions
-
7
FER Token: A Guide to Trading and Acquiring Ferro Protocol's Native Token
-
8
Filecoin (FIL) Price Potential Analysis: Influencing Factors and Market Outlook
-
9
Trump Coin (TRUMP) Future Trend Analysis: Influencing Factors and Market Outlook
-
10
WAHED Coin Analysis: Project Vision, Technology, and Trading Status
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
